BOSTON--(BUSINESS WIRE)--OM1, a leading provider of real-world data (RWD) and AI-driven insights for life sciences, today announced its expansion into Europe to better support pharmaceutical and ...
OM1, a real-world evidence generation company and the leading AI outcomes platform, presented its role in the landmark study that supported FDA approval of Hologic's Aptima HPV Assay for primary ...
BOSTON--(BUSINESS WIRE)--OM1 a leading real-world data, AI and technology company with a focus on chronic diseases, today announced the continued expansion of its Dermatology Network to include ...
Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...